Assessing the potential cost-effectiveness of centralized vs point-of-care testing for hepatitis C virus in Pakistan: a model-based comparison

Joseph B. Babigumira, James K. Karichu, Samantha Clark, Mindy M. Cheng, Louis P. Garrison Jr., Maciej B. Maniecki, Saeed S. Hamid
doi: https://doi.org/10.1101/2022.03.31.22273228

Article Information

doi 
https://doi.org/10.1101/2022.03.31.22273228
History 
  • April 3, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Joseph B. Babigumira1,
  2. James K. Karichu*,2,
  3. Samantha Clark3,
  4. Mindy M. Cheng2,
  5. Louis P. Garrison Jr.3,4,
  6. Maciej B. Maniecki5 and
  7. Saeed S. Hamid6
  1. 1Saw Swee Hock School of Public Health, National University of Singapore, Singapore
  2. 2Global Access & Policy, Roche Diagnostics Solutions, Pleasanton, USA
  3. 3The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, USA
  4. 4VeriTech Corporation, Mercer Island, USA
  5. 5Virology, Roche Molecular Systems, Inc., Pleasanton, USA
  6. 6The Aga Khan University, Karachi, Pakistan
  1. ↵*Corresponding author:
    James K. Karichu, james.karichu{at}roche.com
Back to top
Posted April 03, 2022.
Download PDF
Data/Code
Email
Assessing the potential cost-effectiveness of centralized vs point-of-care testing for hepatitis C virus in Pakistan: a model-based comparison
Joseph B. Babigumira, James K. Karichu, Samantha Clark, Mindy M. Cheng, Louis P. Garrison Jr., Maciej B. Maniecki, Saeed S. Hamid
medRxiv 2022.03.31.22273228; doi: https://doi.org/10.1101/2022.03.31.22273228
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area